Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

GenMark Diagnostics Expands Commercial Team

GlobeNewswire April 30, 2019

GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019

GlobeNewswire April 15, 2019

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel

GlobeNewswire April 15, 2019

GenMark Diagnostics Announces Expansion of Executive Leadership Team

GlobeNewswire February 21, 2019

GenMark Diagnostics to Participate in Upcoming Investor Conferences

GlobeNewswire February 20, 2019

GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019

GlobeNewswire February 7, 2019

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018

GlobeNewswire January 8, 2019

GenMark Bulls Emboldened By Accelerated ePlex Panel Clearance

Benzinga.com  December 27, 2018

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel

GlobeNewswire December 26, 2018

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel

GlobeNewswire December 20, 2018

GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference

GlobeNewswire December 19, 2018

GenMark Diagnostics to Present at Upcoming Investor Conferences

GlobeNewswire November 7, 2018

Analysis: Positioning to Benefit within Hess Midstream Partners LP, Quanta Services, ServiceSource International, Meritor, Donegal Group, and GenMark Diagnostics — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire November 6, 2018

GenMark Diagnostics Reports Third Quarter 2018 Results

GlobeNewswire October 29, 2018

GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018

GlobeNewswire October 15, 2018

Analysis: Positioning to Benefit within PTC, H&R Block, GenMark Diagnostics, American International Group, Newmont Mining, and Stryker — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire October 15, 2018

GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels

GlobeNewswire October 2, 2018

Recent Analysis Shows SUPERVALU INC, GenMark Diagnostics, E.W. Scripps, Cooper Tire & Rubber, Nexstar Broadcasting Group, and Cloud Peak Energy Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire August 13, 2018

GenMark Diagnostics Reports Second Quarter 2018 Results

GlobeNewswire July 30, 2018

GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference

GlobeNewswire July 25, 2018